Cargando…
Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
Once medical drugs and devices are approved for marketing by the FDA they can legally be used for purposes and in ways other than the ones for which they have been tested and approved. However, it is illegal for manufacturers to advertise or promote such unapproved uses of the drugs and devices. Par...
Autor principal: | Van Norman, Gail A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998554/ https://www.ncbi.nlm.nih.gov/pubmed/36908673 http://dx.doi.org/10.1016/j.jacbts.2022.12.011 |
Ejemplares similares
-
Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021) -
Off-label, off-limits? Parental awareness and attitudes towards off-label use in paediatrics
por: Lenk, Christian, et al.
Publicado: (2009) -
The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine
por: Wang, Bo, et al.
Publicado: (2017) -
Off-label prescribing for allergic diseases in children
por: Silva, Diana, et al.
Publicado: (2014) -
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
por: WANG, Weilan, et al.
Publicado: (2013)